Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Preferred Stock Liabilities: 2020-2022

Historic Preferred Stock Liabilities for Mimedx Group (MDXG) over the last 3 years, with Dec 2022 value amounting to $92.5 million.

  • Mimedx Group's Preferred Stock Liabilities changed negligibly% to $92.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $92.5 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $92.5 million for FY2022, which is negligibly% changed negligibly from last year.
  • As of FY2022, Mimedx Group's Preferred Stock Liabilities stood at $92.5 million, which was down 0.00% from $92.5 million recorded in FY2021.
  • Mimedx Group's Preferred Stock Liabilities' 5-year high stood at $92.5 million during FY2021, with a 5-year trough of $91.6 million in FY2020.
  • Its 3-year average for Preferred Stock Liabilities is $92.2 million, with a median of $92.5 million in 2022.
  • Data for Mimedx Group's Preferred Stock Liabilities shows a peak YoY rose of 1.01% (in 2021) over the last 5 years.
  • Over the past 3 years, Mimedx Group's Preferred Stock Liabilities (Yearly) stood at $91.6 million in 2020, then climbed by 1.01% to $92.5 million in 2021, then remained steady at $92.5 million in 2022.